Dermatomyositis and polymyositis (myositis) trials in Norway

4 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)

  Where

  Graalum, Kristiansand S, Stavanger

  Age

  18 years and over

  People

  78 worldwide

  Run by

  Chugai Pharmaceutical Co. Ltd.

  See details and how to join2024-511346-39-00
• Phase 1Taking people
  Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  Where

  Graalum, Kristiansand S, Stavanger

  Age

  18 years to 85 years

  People

  144 worldwide

  Run by

  Chugai Pharmaceutical

  See details and how to joinNCT06371417 · EU 2023-507692-21-00
• Phase 1Enrolling by invitation
  Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

  Where

  Kristiansand, Stavanger

  Age

  18 years to 85 years

  People

  144 worldwide

  Run by

  Chugai Pharmaceutical

  See details and how to joinNCT06723106
• No phaseTaking people
  Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

  Where

  Oslo

  Age

  18 years and over

  People

  218

  Run by

  Oslo University Hospital

  See details and how to joinNCT06732674